Iceland· IS-EU/1/09/609/001

Elonva

A corifollitropin alfa product containing corifollitropinum alfa inn, registered in Iceland by N.V. Organon*. The same ATC class is registered in 10 of our 19 countries.

ATC G03GA09

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedElonvaATCG03GA09REGISTER NO.IS-EU/1/09/609/001PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Corifollitropin alfa is registered in 10 of 19 countries.

Countries holding a registration under ATC G03GA09 (corifollitropin alfa), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose

Corifollitropin alfa · ATC G03GA09

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Corifollitropinum alfa INN
Manufacturer
N.V. Organon*
Country
Iceland (IS)
ATC code
G03GA09
ATC class
Corifollitropin alfa
Defined daily dose
0.15 mg, P
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Corifollitropin alfa in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All corifollitropin alfa products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Liechtenstein · Elonva
  • Norway · Elonva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bc4f6512-38b1-4967-a53d-b5791913fee4
GET /v1/drugs/bc4f6512-38b1-4967-a53d-b5791913fee4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyf, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "G03GA09",
  "marketed": false,
  "strength": "100 míkróg",
  "ma_number": "EU/1/09/609/001",
  "substance": "Corifollitropinum alfa INN",
  "other_info": "Ávísun lyfsins er bundin við sérfræðinga í kvensjúkdómum og fæðingarhjálp,  sérfræðinga í efnaskipta- og innkirtlalækningum og sérfræðinga í barnaefnaskiptalækningum",
  "legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
  "ma_issued_serial": "40219"
}

See everything about corifollitropin alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.